Hypertension and the renin-angiotensin system - Evidence from genetic and transgenic studies

Basic Research in Cardiology

Volumn 93, Issue 2 SUPPL., 1998, Pages 1-6

  Rothermund, L ^a   Paul, M ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

ACE; Angiotensin; Hypertension; Polymorphism; Renin; Transgenic animals

Indexed keywords

ANGIOTENSIN; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DNA POLYMORPHISM; ENDOCRINE SYSTEM; GENETIC MARKER; GENETICS; HUMAN; HYPERTENSION; MOLECULAR CLONING; NONHUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSGENIC ANIMAL;

EID: 0031794785     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s003950050191     Document Type: Article

References (32)

1. Barton M, Shaw S, d'Uscio LV, Moreau P, Luscher TF (1997) Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: Role of ETA receptors for endothelin regulation. Biochem Biophys Res Comm 238: 861-865 (Pubitemid 27472667)
2. Bohlender J, Fukamizu A, Lippoldt A, Nomura T, Dietz R, Menard J, Murakami K, Luft FC, Ganten D (1997) High human renin hypertension in transgenic rats. Hypertension 29: 428-434 (Pubitemid 27074079)
3. Corvol P, Soubrier F, Jeunemaitre X (1997) Molecular genetics of the renin-angiotensin- aldosterone system in human hypertension. Pathol Biol Paris 45: 229-239 (Pubitemid 27207336)
4. Ganten U, Schroder G, Witt M, Zimmermann F, Ganten D, Stock G (1989) Sexual dimorphism of blood pressure in spontaneously hypertensive rats: Effects of anti-androgen treatment. J Hypertens 7: 721-726 (Pubitemid 19230550)
5. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE (1991) Expression of AT2 receptors in the developing rat fetus. J Clin Invest 88: 921-933
6. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK (1995) Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377: 744-747
7. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T (1995) Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377: 748-750
8. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, et al. (1992) Molecular basis of human hypertension: Role of angiotensinogen. Cell 71: 169-180
9. Kimura S, Mullins JJ, Bunnemann B, Metzger R, Hilgenfeldt U, Zimmermann F, Jacob H, Fuxe K, Ganten D, Kaling M (1992) High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J 11: 821-827
10. Krege JH, John SW, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, Smithies O (1995) Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375: 146-148
11. Krege JH, Kim HS, Moyer JS, Jennette JC, Peng L, Hiller SK, Smithies O (1997) Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension 29: 150-157 (Pubitemid 27074036)
12. Lee MA, Bohm M, Paul M, Bader M, Ganten U, Ganten D (1996) Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. Am J Physiol 270: E919-929 (Pubitemid 26298572)
13. Lindpaintner K, Lee M, Larson MG, Rao VS, Pfeffer MA, Ordovas JM, Schaefer EJ, Wilson AF, Wilson PW, Vasan RS, Myers RH, Levy D (1996) Absence of association or genetic linkage between the angiotensinconverting- enzyme gene and left ventricular mass. N Engl J Med 334: 1023-1028 (Pubitemid 26123778)
14. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH (1995) Aprospective evaluation of an angiotensin-converting- enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332: 706-711
15. Lo M, Liu KL, Lantelme P, Sassard J (1995) Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J Clin Invest 95: 1394-1397
16. McDonald KM, Garr M, Carlyle PF, Francis GS, Hauer K, Hunter DW, Parish T, Stillman A, Cohn JN (1994) Relative effects of alpha 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog. Circulation 90: 3034-3046
17. Merrill DC, Thompson MW, Carney CL, Granwehr BP, Schlager G, Robillard JE, Sigmund CD (1996) Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest 97: 1047-1055 (Pubitemid 26070585)
18. Morgan K (1994) Diverse factors influencing angiotensin metabolism during ACE inhibition: Insights from molecular biology and genetic studies. Br Heart J 72 (Suppl): S3-10
19. Mullins JJ, Peters J, Ganten D (1990) Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344: 541-544
20. Mullins JJ, Sigmund CD, Kane Haas-C, Wu CZ, Pacholec F, Zeng Q, Gross KW (1988) Studies on the regulation of renin genes using transgenic mice. Clin Exp Hypertens A 10: 1157-1167 (Pubitemid 19051356)
21. Nickenig G, Laufs U, Schnabel P, Knorr A, Paul M, Bohm MP (1997) Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats. Br J Pharmacol 121: 134-140 (Pubitemid 27192798)
22. Paul M, Wagner J, Kreutz R, Fernandez Alfonso MS, Liu Y, Bader M, Ganten D (1994) Transgenic Rats Expressing Components of the Renin-Angiotensin System: Focus on Cardiovascular Regulation. In Lindpainter K, Ganten D (eds) New York: The Cardiac-Renin Angiotensin System. Futura Publishing Co., Inc., Armonk, pp 289-307
23. Peters J (1995) Molecular basis of human hypertension: The role of angiotensin. Baillieres Clin Endocrinol Metab 9: 657-678
24. Pieruzzi F, Abassi ZA, Keiser HR (1995) Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation 92: 3105-3112
25. Pinto YM, Buikema H, van Gilst WH, Scholtens E, van Geel PP, de Graeff PA, Wagner J, Paul M (1997) Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive rats. J Mol Med 75: 371-377 (Pubitemid 27247969)
26. Schmidt S, Ritz E (1997) Genetics of the renin-angiotensin system and renal disease: A progress report. Curr Opin Nephrol Hypertens 6: 146-151 (Pubitemid 27211776)
27. Schmidt S, Schone N, Ritz E (1995) Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 47: 1176-1181
28. Smits JF, Daemen MJ (1994) Insights from animal models of myocardial infarction: Do ACE inhibitors limit the structural response? Br Heart J 72 (Suppl): S61-64 (Pubitemid 24295525)
29. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T (1995) The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95: 651-657
30. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetiere P et al. (1994) Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 344: 910-913 (Pubitemid 24295876)
31. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S et al. (1993) A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 4: 59-61 (Pubitemid 23165914)
32. Zisman LS, Abraham WT, Meixell GE, Vamvakias BN, Quaife RA, Lowes BD, Roden RL, Peacock SJ, Groves BM, Raynolds MV et al. (1995) Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway. J Clin Invest 96: 1490-1498